The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
4-[2-(4-Fluorophenyl)-4-(1-methyl-1,2,3,6-tetrahydropyridin-4-yl)-1H-pyrrol-3-yl]pyridine ID: ALA1093562
PubChem CID: 9880738
Max Phase: Preclinical
Molecular Formula: C21H20FN3
Molecular Weight: 333.41
Molecule Type: Small molecule
Associated Items:
Names and Identifiers Canonical SMILES: CN1CC=C(c2c[nH]c(-c3ccc(F)cc3)c2-c2ccncc2)CC1
Standard InChI: InChI=1S/C21H20FN3/c1-25-12-8-15(9-13-25)19-14-24-21(17-2-4-18(22)5-3-17)20(19)16-6-10-23-11-7-16/h2-8,10-11,14,24H,9,12-13H2,1H3
Standard InChI Key: CQWRMGCHJURACZ-UHFFFAOYSA-N
Molfile:
RDKit 2D
25 28 0 0 0 0 0 0 0 0999 V2000
4.7580 -0.1002 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.4400 -0.5637 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
6.0916 -0.0584 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.8125 0.7177 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.9881 0.6915 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.5670 1.3987 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.9739 2.1191 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.5536 2.8296 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.7266 2.8210 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
3.3216 2.0959 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.7441 1.3884 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.0466 -0.5170 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.3280 -0.1069 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.6157 -0.5241 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.6207 -1.3512 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.3440 -1.7594 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.0534 -1.3398 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.2315 1.4309 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.0587 1.4257 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.4745 2.1356 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.0677 2.8551 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
6.2404 2.8604 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.8201 2.1460 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.9085 -1.7700 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
7.4862 3.5675 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12 13 2 0
6 7 2 0
13 14 1 0
2 3 1 0
14 15 2 0
7 8 1 0
15 16 1 0
3 4 2 0
16 17 2 0
17 12 1 0
1 12 1 0
18 19 2 0
8 9 2 0
4 5 1 0
9 10 1 0
5 1 2 0
10 11 2 0
11 6 1 0
18 23 1 0
19 20 1 0
20 21 1 0
21 22 1 0
22 23 1 0
4 18 1 0
5 6 1 0
15 24 1 0
1 2 1 0
21 25 1 0
M END Associated Targets(Human) Associated Targets(non-human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 333.41Molecular Weight (Monoisotopic): 333.1641AlogP: 4.60#Rotatable Bonds: 3Polar Surface Area: 31.92Molecular Species: BASEHBA: 2HBD: 1#RO5 Violations: ┄HBA (Lipinski): 3HBD (Lipinski): 1#RO5 Violations (Lipinski): ┄CX Acidic pKa: ┄CX Basic pKa: 8.69CX LogP: 3.57CX LogD: 2.26Aromatic Rings: 3Heavy Atoms: 25QED Weighted: 0.76Np Likeness Score: -0.41
References 1. Nakao A, Ohkawa N, Nagasaki T, Kagari T, Doi H, Shimozato T, Ushiyama S, Aoki K.. (2010) Tetrahydropyridine derivatives with inhibitory activity on the production of proinflammatory cytokines: part 2., 20 (8): [PMID:20346666 ] [10.1016/j.bmcl.2010.03.022 ] 2. Nakao A, Ohkawa N, Nagasaki T, Kagari T, Doi H, Shimozato T, Ushiyama S, Aoki K.. (2010) Tetrahydropyridine derivatives with inhibitory activity on the production of proinflammatory cytokines: part 3., 20 (16): [PMID:20637613 ] [10.1016/j.bmcl.2010.06.122 ]